Filtros de búsqueda

Lista de obras de Krzysztof Jamroziak

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

artículo científico publicado en 2016

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

A polygenic risk score for multiple myeloma risk prediction

artículo científico publicado en 2022

ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.

artículo científico publicado en 2009

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.

artículo científico publicado en 2013

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group

artículo científico publicado en 2009

Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group

scientific article published on 09 September 2020

Association between the CEBPA and c-MYC genes expression levels and acute myeloid leukemia pathogenesis and development

artículo científico publicado en 2020

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations

artículo científico publicado en 2019

Associations of ficolins and mannose-binding lectin with acute myeloid leukaemia in adults

artículo científico publicado en 2020

Autologous stem cell transplantation in the treatment of multiple myeloma with 17p deletion

scientific article published on 14 January 2020

CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.

artículo científico publicado en 2009

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Cereblon expression predicts clinical response in chronic lymphocytic leukemia treated with a thalidomide/fludarabine regimen

artículo científico publicado en 2014

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (

scientific article published on 21 March 2006

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

artículo científico publicado en 2007

Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.

artículo científico publicado en 2014

Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival

scientific article published on 05 November 2020

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms

artículo científico publicado en 2017

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms

artículo científico publicado en 2018

Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk

artículo científico publicado en 2011

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.

artículo científico publicado en 2014

Comorbidity Burden and Use of Concomitant Medications at CML Diagnosis: A Retrospective Analysis of 527 Patients From the Polish Adult Leukemia Group Registry

artículo científico publicado en 2018

Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)

scientific article published on 01 May 2018

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy

artículo científico publicado en 2016

Comparison of cladribine plus cyclophosphamide with fludarabine plus cyclophosphamide as first-line therapy for chronic lymphocytic leukemia: a phase III randomized study by the Polish Adult Leukemia Group (PALG-CLL3 Study).

artículo científico publicado en 2010

Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium

artículo científico publicado en 2012

Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

artículo científico publicado en 2015

Current Treatment of Chronic Lymphocytic Leukemia.

artículo científico publicado en 2017

Current and emerging treatments for chronic lymphocytic leukaemia

artículo científico publicado en 2009

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

Distribution of allelic variants of functional C3435T polymorphism of drug transporter MDR1 gene in a sample of Polish population

scientific article published on 01 September 2002

Do polymorphisms in ABC transporter genes influence risk of childhood acute lymphoblastic leukemia?

artículo científico publicado en 2008

Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)

artículo científico publicado en 2017

Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2019

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors

artículo científico publicado en 2020

Erratum: Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case—control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

scholarly article published in Leukemia

Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia

artículo científico publicado en 2009

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

artículo científico publicado en 2019

Expression level of CEBPA gene in acute lymphoblastic leukemia individuals

scientific article published on 30 October 2019

Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

artículo científico publicado en 2021

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

artículo científico publicado en 2004

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk

artículo científico publicado en 2016

Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations--An Extensive Replication of the Associations from the Candidate Gene Era

article

Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study

artículo científico publicado en 2018

Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

article

Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma

artículo científico publicado en 2007

Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium

artículo científico publicado en 2012

Genetically determined telomere length and multiple myeloma risk and outcome

artículo científico publicado en 2021

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

artículo científico

Genome-wide association study identifies an early onset pancreatic cancer risk locus

scientific article published on 09 April 2020

Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.

artículo científico publicado en 2015

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

artículo científico publicado en 2018

Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.

artículo científico publicado en 2019

Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).

artículo científico publicado en 2017

Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia?

artículo científico publicado en 2007

Ibrutinib discontinuation in patients with relapsed or refractory chronic lymphocytic leukemia treated in a compassionate use program: A report from the Polish Adult Leukemia Study Group (PALG)

scientific article published on 01 August 2019

Identification of miRSNPs associated with the risk of multiple myeloma.

artículo científico publicado en 2016

Immunochemotherapy for Richter syndrome: current insights

artículo científico publicado en 2019

Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

Inheritance and clinical outcome in childhood acute lymphoblastic leukemia

artículo científico publicado en 2009

Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

artículo científico publicado en 2018

Insights on Multiple Myeloma Treatment Strategies

artículo científico publicado en 2018

Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium

artículo científico publicado en 2017

Lack of Replication of Seven Pancreatic Cancer Susceptibility Loci Identified in Two Asian Populations

article

Long-term Efficacy of Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of the Polish Adult Leukemia Study Group Observational Study

artículo científico publicado en 2020

Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.

artículo científico publicado en 2013

MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2006

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

scientific article published on 12 October 2020

Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia

artículo científico publicado en 2005

No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells

scientific article published on 01 October 2006

Overcoming Ibrutinib Resistance in Chronic Lymphocytic Leukemia

scientific article published on 21 November 2019

Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies

artículo científico publicado en 2004

Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction

artículo científico publicado en 2020

Polymorphism of CD44 influences the efficacy of CD34(+) cells mobilization in patients with hematological malignancies

artículo científico publicado en 2014

Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma.

artículo científico publicado en 2008

Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium

artículo científico publicado en 2013

Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case–control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

artículo científico publicado en 2011

Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine

artículo científico publicado en 2012

Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib

artículo científico publicado en 2020

Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic lymphocytic leukemia cells.

artículo científico publicado en 2005

Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.

artículo científico publicado en 2015

Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2014 r. – raport Grupy Roboczej PTHiT oraz PALG – CLL

Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2016 r – Raport Grupy Roboczej PTHiT i PALG-CLL

Relation of P-glycoprotein expression with spontaneous in vitro apoptosis in B-cell chronic lymphocytic leukemia

artículo científico publicado en 2004

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy.

artículo científico

Richter's syndrome in the brain first manifested as an ischaemic stroke

artículo científico publicado en 2004

Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.

artículo científico publicado en 2014

Safe administration of rituximab in patients with chronic lymphocytic leukemia and a history of obinutuzumab‑associated anaphylaxis

scientific article published on 31 August 2018

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility

artículo científico publicado en 2015

The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT)

The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of multiple myeloma patients

artículo científico publicado en 2020

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium

artículo científico publicado en 2015

Variants of CD38 gene and lipid metabolism: a link in chronic lymphocytic leukemia?

artículo científico publicado en 2012

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2015

artículo científico publicado en 2015

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2016

artículo científico publicado en 2016

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2017

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda